QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 watching-shares-of-aptevo-therapeutics-traders-circulating-zacks-investment-research-article-titled-aptevo-therapeutics-apvo-upgraded-to-buy-heres-what-you-should-know-shares-seeing-volume

https://www.zacks.com/stock/news/2322717/aptevo-therapeutics-apvo-upgraded-to-buy-heres-what-you-should-know

 aptevo-therapeutics-q2-eps-167-beats-392-estimate

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(1.67) per share which beat the analyst consensus estimate of $...

 aptevo-therapeutics-announces-275m-offering-of-5339806-shares-of-its-common-stock-or-pre-funded-warrants-in-lieu-thereof-and-warrants-to-purchase-up-to-an-aggregate-of-10679612-shares-of-its-common-stock-at-a-purchase-price-of-0515-per-share-and-associated-warrant

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology ther...

 aptevo-therapeutics-has-been-granted-canadian-patent-number-2999138-titled--cd3-binding-polypeptides-for-the-treatment-of-cancer

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2999138/summary.html

 aptevo-therapeutics-q1-eps-995-beats-1284-estimate

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(9.95) per share which beat the analyst consensus estimate of $...

 nasdaq-jumps-250-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

 why-aptevo-therapeutics-stock-is-cratering

Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereo...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION